GreenLight Biosciences grabs $50 mln
Boston-based GreenLight Biosciences Inc, a developer of RNA-based solutions for agriculture and pharmaceutical applications, has secured $50 million in funding. S2G Ventures, Baird Capital and Blue I/O led the round.
8 January 2019•1 min read
